LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 151

Search options

  1. Article ; Online: Experimental heart failure models in small animals.

    Gunata, Mehmet / Parlakpinar, Hakan

    Heart failure reviews

    2022  Volume 28, Issue 2, Page(s) 533–554

    Abstract: Heart failure (HF) is one of the most critical health and economic burdens worldwide, and its prevalence is continuously increasing. HF is a disease that occurs due to a pathological change arising from the function or structure of the heart tissue and ... ...

    Abstract Heart failure (HF) is one of the most critical health and economic burdens worldwide, and its prevalence is continuously increasing. HF is a disease that occurs due to a pathological change arising from the function or structure of the heart tissue and usually progresses. Numerous experimental HF models have been created to elucidate the pathophysiological mechanisms that cause HF. An understanding of the pathophysiology of HF is essential for the development of novel efficient therapies. During the past few decades, animal models have provided new insights into the complex pathogenesis of HF. Success in the pathophysiology and treatment of HF has been achieved by using animal models of HF. The development of new in vivo models is critical for evaluating treatments such as gene therapy, mechanical devices, and new surgical approaches. However, each animal model has advantages and limitations, and none of these models is suitable for studying all aspects of HF. Therefore, the researchers have to choose an appropriate experimental model that will fully reflect HF. Despite some limitations, these animal models provided a significant advance in the etiology and pathogenesis of HF. Also, experimental HF models have led to the development of new treatments. In this review, we discussed widely used experimental HF models that continue to provide critical information for HF patients and facilitate the development of new treatment strategies.
    MeSH term(s) Animals ; Humans ; Disease Models, Animal ; Heart Failure ; Heart
    Language English
    Publishing date 2022-12-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1336499-6
    ISSN 1573-7322 ; 1382-4147
    ISSN (online) 1573-7322
    ISSN 1382-4147
    DOI 10.1007/s10741-022-10286-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Effects of Low- and High-Dose Valproic Acid and Lamotrigine on the Heart in Female Rats.

    Yıldız, Azibe / Vardı, Nigar / Parlakpınar, Hakan / Ateş, Burhan / Çolakoğlu, Neriman

    Cardiovascular toxicology

    2022  Volume 22, Issue 4, Page(s) 326–340

    Abstract: Epilepsy is a chronic neurological disease that affects more than 50 million people worldwide. Antiepileptic drugs (AEDs) are the mainstay of treatment for most patients with epilepsy. However, AEDs have been reported to be associated with adverse ... ...

    Abstract Epilepsy is a chronic neurological disease that affects more than 50 million people worldwide. Antiepileptic drugs (AEDs) are the mainstay of treatment for most patients with epilepsy. However, AEDs have been reported to be associated with adverse cardiac effects. In this study, it was aimed to investigate the possible cardiac effects of low-dose (LD) and high-dose (HD) treatment of valproic acid (VPA) and lamotrigine (LTG), which are commonly used AEDs, in rats without epilepsy. Rats were randomly grouped as control, LD-VPA, HD-VPA, LD-LTG, and HD-LTG. The cardiac effects of AEDs were evaluated using immunohistological, biochemical, and hemodynamic parameters. A dose-dependent increase in the intensity of caspase-3 staining was detected in the VPA and LTG groups. The intensity of connexin-43 and troponin-T staining in the VPA groups and desmin staining in the LTG groups was significantly reduced. Biochemically, HD-VPA and HD-LTG administrations caused a significant increase in MDA level in myocardial tissue. In addition, as a result of hemodynamic evaluations, cardiac functions were found to be affected and blood pressure increased in HD-LTG group. The results of present study support that VPA and LTG treatment can increase cardiac risk markers.
    MeSH term(s) Animals ; Anticonvulsants/toxicity ; Epilepsy/drug therapy ; Female ; Humans ; Lamotrigine/therapeutic use ; Lamotrigine/toxicity ; Rats ; Triazines/therapeutic use ; Triazines/toxicity ; Valproic Acid/toxicity
    Chemical Substances Anticonvulsants ; Triazines ; Valproic Acid (614OI1Z5WI) ; Lamotrigine (U3H27498KS)
    Language English
    Publishing date 2022-01-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2036765-X
    ISSN 1559-0259 ; 1530-7905
    ISSN (online) 1559-0259
    ISSN 1530-7905
    DOI 10.1007/s12012-021-09714-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.

    Parlakpinar, Hakan / Gunata, Mehmet

    Immunopharmacology and immunotoxicology

    2021  Volume 43, Issue 6, Page(s) 651–665

    Abstract: Immunosuppressive drugs used in the transplantation period are generally defined as induction and maintenance therapy. The use of immunosuppressants, which are particularly useful and have fewer side effects, decreased both mortality and morbidity. Many ... ...

    Abstract Immunosuppressive drugs used in the transplantation period are generally defined as induction and maintenance therapy. The use of immunosuppressants, which are particularly useful and have fewer side effects, decreased both mortality and morbidity. Many drugs such as steroids, calcineurin inhibitors (cyclosporine-A, tacrolimus), antimetabolites (mycophenolate mofetil, azathioprine), and mTOR inhibitors (sirolimus, everolimus) are used as immunosuppressive agents. Although immunosuppressant drugs cause many side effects such as hypertension, infection, and hyperlipidemia, they are the agents that should be used to prevent organ rejection. This shows the importance of individualized drug use. The optimal immunosuppressive therapy post-transplant is not established. Therefore, discovering less toxic but more potent new agents is of great importance, and new experimental and clinical studies are needed in this regard.Our review discussed the mechanism of immunosuppressants, new agents' discovery, and current therapeutic protocols in the transplantation.
    MeSH term(s) Abatacept/pharmacology ; Abatacept/therapeutic use ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Clinical Trials as Topic/methods ; Cyclosporine/pharmacology ; Cyclosporine/therapeutic use ; Graft Rejection/immunology ; Graft Rejection/prevention & control ; Humans ; Immunosuppression Therapy/methods ; Immunosuppressive Agents/pharmacology ; Immunosuppressive Agents/therapeutic use ; Organ Transplantation/adverse effects ; Organ Transplantation/trends ; Transplants/drug effects ; Transplants/immunology
    Chemical Substances Immunosuppressive Agents ; voclosporin (2PN063X6B1) ; Bortezomib (69G8BD63PP) ; Abatacept (7D0YB67S97) ; Cyclosporine (83HN0GTJ6D)
    Language English
    Publishing date 2021-08-20
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 807033-7
    ISSN 1532-2513 ; 0892-3973
    ISSN (online) 1532-2513
    ISSN 0892-3973
    DOI 10.1080/08923973.2021.1966033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatment.

    Gunata, Mehmet / Parlakpinar, Hakan

    Cell biochemistry and function

    2020  Volume 39, Issue 2, Page(s) 190–217

    Abstract: Cardiovascular diseases are known to be the most fatal diseases worldwide. Ischaemia/reperfusion (I/R) injury is at the centre of the pathology of the most common cardiovascular diseases. According to the World Health Organization estimates, ischaemic ... ...

    Abstract Cardiovascular diseases are known to be the most fatal diseases worldwide. Ischaemia/reperfusion (I/R) injury is at the centre of the pathology of the most common cardiovascular diseases. According to the World Health Organization estimates, ischaemic heart disease is the leading global cause of death, causing more than 9 million deaths in 2016. After cardiovascular events, thrombolysis, percutaneous transluminal coronary angioplasty or coronary bypass surgery are applied as treatment. However, after restoring coronary blood flow, myocardial I/R injury may occur. It is known that this damage occurs due to many pathophysiological mechanisms, especially increasing reactive oxygen types. Besides causing cardiomyocyte death through multiple mechanisms, it may be an important reason for affecting other cell types such as platelets, fibroblasts, endothelial and smooth muscle cells and immune cells. Also, polymorphonuclear leukocytes are associated with myocardial I/R damage during reperfusion. This damage may be insufficient in patients with co-morbidity, as it is demonstrated that it can be prevented by various endogenous antioxidant systems. In this context, the resulting data suggest that optimal cardioprotection may require a combination of additional or synergistic multi-target treatments. In this review, we discussed the pathophysiology, experimental models, biomarkers, treatment and its relationship with genetics in myocardial I/R injury. SIGNIFICANCE OF THE STUDY: This review summarized current information on myocardial ischaemia/reperfusion injury (pathophysiology, experimental models, biomarkers, genetics and pharmacological therapy) for researchers and reveals guiding data for researchers, especially in the field of cardiovascular system and pharmacology.
    MeSH term(s) Animals ; Antioxidants/chemistry ; Antioxidants/metabolism ; Biomarkers/metabolism ; Humans ; Models, Biological ; Myocardial Infarction/metabolism ; Myocardial Infarction/pathology ; Myocardial Infarction/therapy ; Myocardial Reperfusion Injury/drug therapy ; Myocardial Reperfusion Injury/metabolism ; Myocardial Reperfusion Injury/pathology ; Oxidative Stress ; Reactive Oxygen Species/metabolism ; Troponin/metabolism
    Chemical Substances Antioxidants ; Biomarkers ; Reactive Oxygen Species ; Troponin
    Language English
    Publishing date 2020-09-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 283643-9
    ISSN 1099-0844 ; 0263-6484
    ISSN (online) 1099-0844
    ISSN 0263-6484
    DOI 10.1002/cbf.3587
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.

    Parlakpinar, Hakan / Gunata, Mehmet

    Cell biochemistry and function

    2020  Volume 39, Issue 1, Page(s) 10–28

    Abstract: COVID-19 caused by SARS-COV-2 first appeared in the Wuhan City of China and began to spread rapidly among people. Rapid progression of the outbreak has led to a major global public health problem of a potentially fatal disease. On January 30, 2020, WHO ... ...

    Abstract COVID-19 caused by SARS-COV-2 first appeared in the Wuhan City of China and began to spread rapidly among people. Rapid progression of the outbreak has led to a major global public health problem of a potentially fatal disease. On January 30, 2020, WHO declared the pandemic as the sixth public health emergency of the world. Upon this, the whole country has started to take the necessary precautions. The new coronavirus uses membrane-bound angiotensin-converting enzyme 2 (ACE2) to enter into the cells, such as SARS-CoV, and mostly affects the respiratory tract. Symptoms of COVID-19 patients include fever (93%), fatigue (70%), cough (70%), anorexia (40%) and dyspnoea (34.5%). The elderly and people with underlying chronic diseases are more susceptible to infection and higher mortality. Currently, a large number of drugs and vaccines studies are ongoing. In this review, we discussed the virology, epidemiological data, the replication of the virus, and its relationship with cardiovascular diseases on COVID-19 pandemics, treatment and vaccines. Thereby, this study aims to neatly present scientific data in light of many regarding literature that can be a clue for readers who research this disease prevention and treatment. SIGNIFICANCE OF THE STUDY: This review summarized current information on COVID-19 (epidemiology, pathophysiology, clinical, laboratory, cardiovascular diseases, ACE2 and pharmacological agents) for researchers and reveals guiding data for researchers, especially in the field of cardiovascular system, pharmacology, dysregulation of cellular function in disease, molecular and cell biology and physiology in the regulation of tissue function in health and disease.
    MeSH term(s) Age Factors ; Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/metabolism ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; COVID-19/epidemiology ; COVID-19/genetics ; COVID-19/metabolism ; Humans ; Pandemics ; SARS-CoV-2/pathogenicity ; SARS-CoV-2/physiology ; Virus Replication
    Chemical Substances Antiviral Agents ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-09-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 283643-9
    ISSN 1099-0844 ; 0263-6484
    ISSN (online) 1099-0844
    ISSN 0263-6484
    DOI 10.1002/cbf.3591
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Enhancement of enzyme activity by laser-induced energy propulsion of upconverting nanoparticles under near-infrared light: A comprehensive methodology for in vitro and in vivo applications.

    Ateş, Burhan / Ulu, Ahmet / Asiltürk, Meltem / Noma, Samir Abbas Ali / Topel, Seda Demirel / Dik, Gamze / Özhan, Onural / Bakar, Büşra / Yıldız, Azibe / Vardı, Nigar / Parlakpınar, Hakan

    International journal of biological macromolecules

    2024  Volume 260, Issue Pt 2, Page(s) 129343

    Abstract: If the appropriate immobilization method and carrier support are not selected, partial decreases in the activity of enzymes may occur after immobilization. Herein, to overcome this challenge, an excitation mechanism that enables energy transfer was ... ...

    Abstract If the appropriate immobilization method and carrier support are not selected, partial decreases in the activity of enzymes may occur after immobilization. Herein, to overcome this challenge, an excitation mechanism that enables energy transfer was proposed. Modified upconverting nanoparticles (UCNPs) were constructed and the important role of near-infrared (NIR) excitation in enhancing the catalytic activity of the enzyme was demonstrated. For this purpose, UCNPs were first synthesized via the hydrothermal method, functionalized with isocyanate groups, and then, PEG-L-ASNase was immobilized via covalent binding. UCNPs with and without PEG-L-ASNase were extensively characterized by different methods. These supports had immobilization yield and activity efficiency of >96 % and 78 %, respectively. Moreover, immobilized enzymes exhibited improved pH, thermal, and storage stability. In addition, they retained >65 % of their initial activity even after 20 catalytic cycles. Biochemical and histological findings did not indicate a trend of toxicity in rats due to UCNPs. Most importantly, PEG-L-ASNase activity was triggered approximately 5- and 2-fold under in vitro and in vivo conditions, respectively. Overall, it is anticipated that this pioneering work will shed new light on the realistic and promising usage of NIR-excited UCNPs for the immobilization of enzymes in expensive and extensive applications.
    MeSH term(s) Animals ; Rats ; Nanoparticles/chemistry ; Enzymes, Immobilized/chemistry ; Infrared Rays ; Catalysis
    Chemical Substances Enzymes, Immobilized
    Language English
    Publishing date 2024-01-17
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 282732-3
    ISSN 1879-0003 ; 0141-8130
    ISSN (online) 1879-0003
    ISSN 0141-8130
    DOI 10.1016/j.ijbiomac.2024.129343
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.

    Ermis, Necip / Ulutas, Zeynep / Ozhan, Onural / Yildiz, Azibe / Vardi, Nigar / Colak, Cemil / Parlakpinar, Hakan

    Biotechnic & histochemistry : official publication of the Biological Stain Commission

    2023  Volume 98, Issue 5, Page(s) 326–335

    Abstract: Doxorubicin (DOX) is an anthracycline derivative used for treatment of malignancies; however, its clinical use is limited by its cardiotoxicity. We investigated the effects of angiotensin II type 2 receptor agonist compound 21 (C21) on DOX induced heart ... ...

    Abstract Doxorubicin (DOX) is an anthracycline derivative used for treatment of malignancies; however, its clinical use is limited by its cardiotoxicity. We investigated the effects of angiotensin II type 2 receptor agonist compound 21 (C21) on DOX induced heart failure in rat heart. We compared C21 with losartan (LOS), an AT 1 receptor antagonist used for treating heart failure. We allocated 40 rats into five groups of eight: saline treated control group, DOX group administered a single 20 mg/kg dose of DOX, DOX + C21 group administered 0.3 mg/kg C21 for 21 days following the 20 mg/kg dose of DOX, DOX + losartan (LOS) group administered a 21 day regimen of 20 mg/kg LOS following the single dose of DOX, and a DOX + LOS + C21 group administered 0.3 mg/kg C21 and 20 mg/kg LOS for 21 days following the single dose of DOX. We assessed histopathology and conducted echocardiograpic and hemodynamic measurements. Left ventricular ejection fraction (EF) was reduced only in the DOX treated group. C21, LOS and C21 + LOS therapy prevented decreased EF due to DOX. Less histopathology was observed in the DOX + LOS + C21 group than for the other treatment groups. Application of C21 decreased DOX induced cardiac injury similar to LOS. Combined use of C21 and LOS was most beneficial for DOX induced heart failure.
    MeSH term(s) Rats ; Animals ; Losartan/pharmacology ; Losartan/therapeutic use ; Stroke Volume ; Receptor, Angiotensin, Type 2/agonists ; Ventricular Function, Left ; Heart Failure/chemically induced ; Heart Failure/drug therapy ; Doxorubicin/pharmacology
    Chemical Substances Losartan (JMS50MPO89) ; compound 21 (RC2V4W0EYC) ; Receptor, Angiotensin, Type 2 ; Doxorubicin (80168379AG)
    Language English
    Publishing date 2023-03-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 1069349-x
    ISSN 1473-7760 ; 1052-0295
    ISSN (online) 1473-7760
    ISSN 1052-0295
    DOI 10.1080/10520295.2023.2187461
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Does apocynin increase liver regeneration in the partial hepatectomy model?

    Bilgiç, Yılmaz / Kanat, Burhan Hakan / Özhan, Onural / Yıldız, Azibe / Aksungur, Zeynep / Erdemli, Mehmet Erman / Vardı, Nigar / Türköz, Yusuf / Akbulut, Sami / Köse, Adem / Parlakpınar, Hakan

    Turkish journal of medical sciences

    2023  Volume 53, Issue 3, Page(s) 647–658

    Abstract: Background: Hepayocyte loss may develop secondary to liver surgery and at this point liver regeneration plays a significant act in terms of liver reserve. The purpose of this research was to investigate the efficacy of apocynin on liver regeneration and ...

    Abstract Background: Hepayocyte loss may develop secondary to liver surgery and at this point liver regeneration plays a significant act in terms of liver reserve. The purpose of this research was to investigate the efficacy of apocynin on liver regeneration and preservation after partial hepatectomy in rats.
    Methods: A total of 32 rats, have been divided into 4 groups (n: 8) for hepatectomy model. Inflammatory and antiinflammatory parameters were measured from blood and liver tissue samples. In addition, the effects of apocynin were examined immunohistochemically and histopathologically from liver tissue.
    Results: In liver tissue samples, a significant difference has been found in glutathione peroxidase, total nitrite, catalase, oxidative stress index, total antioxidant and total oxidant status between sham and hepatectomy groups. A significant difference has been achieved between hepatectomy and posthepatectomy-Apocynin in terms of glutathione peroxidase and oxidative stress index. Total antioxidant status, oxidative stress index, and total oxidant status were significantly different only between the sham and the hepatectomy groups. Statistical differences were found between sham and hepatectomy groups and between hepatectomy and pre+post-hepatectomy-Apocynin groups in terms of serum glutathione, malondialdehyde, total nitrite, and L-Arginine. There were significant differences between the sham and hepatectomy groups, between hepatectomy and posthepatectomy-apocynin groups, between posthepatctomy-apocynin and pre+posthepatectomy-apocynin groups in terms of sinusoidal dilatation, intracytoplasmic vacuolization and glycogen loss (p < 0.001), in all histopathologic parameters except sinusoidal dilatation (p < 0.05). However, significant Ki-67 increases have been elaborated in hepatectomy, posthepatectomy-apocynin, and pre+posthepatectomy-apocynin groups compared to sham group (p < 0.001), in pre+posthepatectomy apocynin group compared to hepatectomy and posthepatectomy-apocynin groups (p < 0.001).
    Discussion: Histopathology, immunohistochemistry, and biochemistry results of this study revealed that apocynin has a protective effect on enhancing liver regeneration in partial hepatectomy cases in rats.
    MeSH term(s) Rats ; Animals ; Hepatectomy ; Liver Regeneration ; Antioxidants/pharmacology ; Nitrites/pharmacology ; Liver/surgery ; Oxidants ; Glutathione Peroxidase
    Chemical Substances acetovanillone (B6J7B9UDTR) ; Antioxidants ; Nitrites ; Oxidants ; Glutathione Peroxidase (EC 1.11.1.9)
    Language English
    Publishing date 2023-06-19
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 1183461-4
    ISSN 1303-6165 ; 1300-0144
    ISSN (online) 1303-6165
    ISSN 1300-0144
    DOI 10.55730/1300-0144.5627
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The effect of genistein on cisplatin induced ototoxicity and oxidative stress.

    Tan, Mehmet / Toplu, Yüksel / Varan, Emrah / Sapmaz, Emrah / Özhan, Onural / Parlakpınar, Hakan / Polat, Alaadin

    Brazilian journal of otorhinolaryngology

    2021  Volume 88, Issue 1, Page(s) 105–111

    Abstract: Objective: Cisplatin is an antineoplastic agent used in adults and children for the treatment of various malignant diseases. It can cause irreversible ototoxicity. Genistein is a phytoestrogen. Genistein functions as an antioxidant and cell cycle ... ...

    Abstract Objective: Cisplatin is an antineoplastic agent used in adults and children for the treatment of various malignant diseases. It can cause irreversible ototoxicity. Genistein is a phytoestrogen. Genistein functions as an antioxidant and cell cycle inhibitor by inhibiting the DNA topoisomerase and tyrosine protein kinase enzymes. The protective effect of genistein in preventing cisplatin-induced ototoxicity and levels of the oxidative stress was investigated.
    Methods: 32 Sprague Dawley rats were used in 4 groups (control, cisplatin, cisplatin + genistein, genistein). Otoacoustic emission measurements of the distortion product were performed on the 1st, 2nd and 5th days of the test protocol. Serum malondialdehyde, superoxide dismutase, catalase, glutathione peroxidase, total antioxidant status, total oxidant status and oxidative stress index measurements were made.
    Results: The hearing of the cisplatin + genistein group was found to be better than that of the cisplatin group. While the malondialdehyde, total oxidant status and oxidative stress index parameters decreased significantly in the cisplatin + genistein group compared to the cisplatin group, superoxide dismutase increased significantly (p < 0.05).
    Conclusion: Genistein showed positive effects against ototoxicity with its antioxidant effect.
    Level of evidence: Level 3.
    MeSH term(s) Animals ; Antineoplastic Agents/toxicity ; Antioxidants/pharmacology ; Cisplatin/toxicity ; Cochlea ; Genistein/pharmacology ; Ototoxicity ; Oxidative Stress ; Rats ; Rats, Sprague-Dawley
    Chemical Substances Antineoplastic Agents ; Antioxidants ; Genistein (DH2M523P0H) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2021-07-30
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 2428110-4
    ISSN 1808-8686 ; 1808-8694
    ISSN (online) 1808-8686
    ISSN 1808-8694
    DOI 10.1016/j.bjorl.2021.07.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: SARS‐COV ‐2 ( COVID ‐19)

    Parlakpinar, Hakan / Gunata, Mehmet

    Cell Biochemistry and Function ; ISSN 0263-6484 1099-0844

    Cellular and biochemical properties and pharmacological insights into new therapeutic developments

    2020  

    Keywords Clinical Biochemistry ; Cell Biology ; Biochemistry ; General Medicine ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1002/cbf.3591
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top